Evaluating Safety and Ethical Implications of Androgenetic Alopecia Treatments: A Comparison of Direct-to-Consumer Platforms and Dermatologist Visits

December 2024 in “ Journal of the American Academy of Dermatology ”

Michael M. Ong, Shari R. Lipner

androgenetic alopecia direct-to-consumer platforms dermatologist visits oral minoxidil finasteride AGA DTC platforms Rogaine Propecia

TLDR Dermatologist visits offer safer and more ethical treatment for hair loss than direct-to-consumer platforms.

The document discusses the safety and ethical implications of using direct-to-consumer (DTC) platforms for treating androgenetic alopecia (AGA) compared to traditional dermatologist visits. It highlights that while DTC platforms provide convenient access to treatments like oral minoxidil and finasteride, they come with higher costs and reduced medical oversight. The authors argue that focusing solely on financial aspects oversimplifies the complexities involved in managing AGA, emphasizing the need for a comprehensive evaluation of clinical, safety, and ethical considerations from a dermatologist's perspective.

View this study on jaad.org →

Discuss this study in the Community →

Similar Research

5 / 1000+ results

research Digital Health Platforms Expand Access and Improve Care for Male Androgenetic Alopecia

October 2022 in “International Journal of Dermatology”

Digital health platforms improve treatment for male pattern hair loss.

research Patient-Reported Outcomes and Safety of Direct-to-Consumer Teledermatology for Finasteride in Male Androgenetic Alopecia

January 2023 in “DIGITAL HEALTH”

Most men using teledermatology for hair loss treatment saw improved hair and self-esteem, with some experiencing side effects.

research Proceedings of the Ninth World Congress for Hair Research 2015

January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

research Interventions for Female Pattern Hair Loss

21 citations, May 2016 in “The Cochrane library”

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

research Interventions for Female Pattern Hair Loss

35 citations, May 2012 in “Cochrane Database of Systematic Reviews”

Minoxidil effectively treats female pattern hair loss.

Evaluating Safety and Ethical Implications of Androgenetic Alopecia Treatments: A Comparison of Direct-to-Consumer Platforms and Dermatologist Visits

Related Community Posts Join

community He used Dutasteride for 20 years. Interview

community Upcoming Setipiprant clinical trials hint at systemic daily dosage

community How do we only have two treatments to combat hair loss at this point in time?

community Red Ginseng Extract Promotes the Hair Growth in Cultured Human Hair Follicles

community Peptides that Stop Hair Loss? | In-depth Literature Review Video

community Taking Charge of Your Hair: The "Big 3 Stack" Explained for 2023

Similar Research

research Digital Health Platforms Expand Access and Improve Care for Male Androgenetic Alopecia

research Patient-Reported Outcomes and Safety of Direct-to-Consumer Teledermatology for Finasteride in Male Androgenetic Alopecia

research Proceedings of the Ninth World Congress for Hair Research 2015

research Interventions for Female Pattern Hair Loss

research Interventions for Female Pattern Hair Loss